Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Petros Pharmaceuticals In...

    NASDAQ: PTPI · Real-Time Price · USD
    0.15
    -0.05 (-23.86%)
    At close: May 07, 2025, 3:59 PM
    0.14
    -3.10%
    After-hours: May 07, 2025, 07:59 PM EDT
    -23.86%
    Bid 0.14
    Market Cap 310.62K
    Revenue (ttm) 5.11M
    Net Income (ttm) -20.18M
    EPS (ttm) -83.5
    PE Ratio (ttm) n/a
    Forward PE -0.18
    Analyst n/a
    Ask 0.15
    Volume 8,093,775
    Avg. Volume (20D) 3,321,168
    Open 0.19
    Previous Close 0.20
    Day's Range 0.14 - 0.19
    52-Week Range 0.14 - 18.00
    Beta 2.20

    About PTPI

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol PTPI
    Website n/a
    Full Company Profile

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    2 months ago
    -53.42%
    Petros Pharmaceuticals shares are trading lower af... Unlock content with Pro Subscription
    4 months ago
    +0.99%
    Retros Pharmaceuticals shares are trading higher after the company announced it's in a position to lead the Rx-To-OTC switch market with its proprietary AI and quantum computing platform.
    news image

    1 day ago · accessnewswire.com

    Petros Pharmaceuticals Strengthens Partnership with Market Leading Big Data Provider Implementing Key Enhancements to its AI Platform

    Company continues to innovate and develop its SaaS-based platform to facilitate Rx-to-OTC switch in line with recent President Trump Executive Order NEW YORK, NY / ACCESS Newswire / May 6, 2025 / Petr...

    news image

    6 days ago · accessnewswire.com

    Petros Pharmaceuticals Developing First-in-Industry SaaS Platform Utilizing AI and Electronic Health Records Intended to Facilitate Rx-OTC Switches

    Licensable platform intended to facilitate industry compliance with President Trump's recent Executive Order to expand access to medicines through OTC approvals under his Make America Healthy Again (M...

    news image

    1 week ago · accessnewswire.com

    Petros Proprietary Technology Platform Aligns with April 15, 2025 President Trump Executive Order Advancing Rx-to-OTC Reclassification Reforms

    Company's AI and Big Data technology positioned to drive strong industry collaboration Company also announces certain corporate actions NEW YORK, NY / ACCESS Newswire / April 29, 2025 / Petros Pharmac...

    news image

    1 month ago · accessnewswire.com

    Petros Pharmaceuticals to Partner with Renowned Big Data Provider to Enable Rx-to-OTC Switch Across Multiple Indications

    Company to integrate industry leading big data technology solutions into its AI-driven platform to expand capabilities in identifying eligible patients to receive formerly Rx medications over the coun...

    news image

    2 months ago · accessnewswire.com

    Petros Pharmaceuticals' Proprietary Technology Demonstrates Positive Data in Pivotal Study

    Proprietary technology utilizing AI and big data integrations to enable Rx to OTC switch candidates across multiple indications NEW YORK, NY / ACCESS Newswire / February 25, 2025 / Petros Pharmaceutic...

    news image

    2 months ago · accessnewswire.com

    Petros Pharmaceuticals Announces Pricing of $9.6 Million Public Offering of Common Stock and Warrants

    NEW YORK, NY / ACCESS Newswire / February 18, 2025 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) ("Petros" or the "Company"), a company focused on expanding consumer access to medication through over-t...

    Add to Watchlist